Latest filingSep 02, 2026Most recent Form 4
NRIX
Nurix Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$18.6M3 sells
Net open-market-$18.6M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period7transactions
- M · Option exercise · dominant4 · 57%
- S · Open-market sells3 · 43%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- CLO · dominant4 · 57%
- CSO3 · 43%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeRing ChristineCommon Stock · Direct
9,110Sep 02, 2026
Hansen GwennCommon Stock · Direct
117,227Sep 01, 2026
Hansen GwennEmployee Stock Option (right to buy) · Direct
60,858Sep 01, 2026
Ring ChristineEmployee Stock Option (right to buy) · Direct
117,037Sep 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- RC-$98.6k
- HG-$34.3k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
NRIX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Ring Christine | CLO | exercise10b5-1 | 5.78k | $0 | M | — | 0.0% | 09/02 | 09/02 |
| NRIX | Ring Christine | CLO | sale10b5-1 | 400 | -$1.06M | S | — | 0.0% | 09/02 | 09/02 |
| NRIX | Ring Christine | CLO | sale10b5-1 | 5.38k | -$13.8M | S | — | 0.0% | 09/02 | 09/02 |
| NRIX | Ring Christine | CLO | exercise10b5-1 | 5.78k | $5.04M | M | — | 0.0% | 09/02 | 09/02 |
| NRIX | Hansen Gwenn | CSO | exercise10b5-1 | 1.45k | $0 | M | 0.0% | 09/01 | 09/01 | |
| NRIX | Hansen Gwenn | CSO | sale10b5-1 | 1.45k | -$3.69M | S | 0.0% | 09/01 | 09/01 | |
| NRIX | Hansen Gwenn | CSO | exercise10b5-1 | 1.45k | $270k | M | 0.0% | 09/01 | 09/01 |
Nurix Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Nurix Therapeutics, Inc.?
Ring Christine, Hansen Gwenn.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Ring Christine reported a sale on Sep 02, 2026 valued at $1.06M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $186,054.79. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.